3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
20
Lymphoma
5
Lymphoma, B-Cell, Marginal Zone
4
Lymphoma, Follicular
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Neoplasms
2
Leukemia, B-Cell
2
Stomach Neoplasms
1
Hodgkin Disease
1
Interventions
ofatumumab
3
venetoclax
2
pirtobrutinib
2
obinutuzumab
2
ibrutinib
2
Chlorambucil
2
acalabrutinib
1
Tablets
1
Observation
1
Cholecalciferol
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, B-Cell
×
Chlorambucil
×
Clear all
NCT00748189
2019-06-25
COMPLEMENT 1
Novartis
Phase 3
Terminated
447 enrolled
32 charts
NCT01678430
2012-10-15
RIAltO
University of Liverpool
Phase 3
Unknown
670 enrolled